ASRS
KDNY

Arizona State Retirement System’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Arizona State Retirement System’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,946
Closed -$497K – 2212
2023
Q2 		$497K Buy
12,946
+904
+8% +$23.2K ﹤0.01% 1411
2023
Q1 		$279K Buy
12,042
+506
+4% +$12.1K ﹤0.01% 1753
2022
Q4 		$302K Buy
11,536
+746
+7% +$16.5K ﹤0.01% 1680
2022
Q3 		$212K Buy
10,790
+29
+0.3% +$582 ﹤0.01% 1857
2022
Q2 		$188K Buy
+10,761
New +$169K ﹤0.01% 1957

Arizona State Retirement System's KDNY Position: Q3 2023 in Review

Arizona State Retirement System sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 12,946 shares — an estimated $497K sold.

Arizona State Retirement System first reported a position in KDNY in Q2 2022 and held it in 5 quarters. The position peaked at $497K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

  • Arizona State Retirement System reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 12,946 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $497K.
  • Arizona State Retirement System first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Arizona State Retirement System's Chinook Therapeutics, Inc. Common Stock position peaked at $497K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Arizona State Retirement System's 13F filing for Q3 2023, filed 7 Nov 2023.